Life Edit Therapeutics

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Novo Nordisk and Life Edit Therapeutics Establish Multi-Target Collaboration to Discover and Develop Gene Editing Therapies for Rare and Cardiometabolic...

Details:

Under the collaboration, Novo Nordisk will leverage Life Edit’s suite of gene editing technologies to precisely edit the genome with the aim of developing therapies for rare genetic disorders and cardiometabolic diseases allowing for the development of up to seven programmes.

Lead Product(s): Undisclosed

Therapeutic Area: Rare Diseases and Disorders Product Name: Undisclosed

Highest Development Status: DiscoveryProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Novo Nordisk

Deal Size: $1,920.0 million Upfront Cash: Undisclosed

Deal Type: Collaboration May 24, 2023

ASK
US

Upload
your Marketing & Sales content

Life Edit Therapeutics

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Moderna And Life Edit Therapeutics Enter Strategic Collaboration To Accelerate The Development Of Novel In Vivo Gene Editing Therapies

Details:

The partnership will combine Life Edit's suite of proprietary gene editing technologies, including base editing, with Moderna's mRNA platform to advance in vivo gene editing mRNA-based therapies against a select set of therapeutic targets.

Lead Product(s): mRNA-based Therapy

Therapeutic Area: Technology Product Name: Undisclosed

Highest Development Status: Discovery PlatformProduct Type: Large molecule

Partner/Sponsor/Collaborator: Moderna Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration February 22, 2023

ASK
US

Upload
your Marketing & Sales content